3 Mar 2017 14:35
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Redx Pharma plc | ||||||||
2. Reason for the notification (please tick the appropriate box or boxes): | |||||||||
An acquisition or disposal of voting rights | x | ||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||||||
An event changing the breakdown of voting rights | |||||||||
Other (please specify): | |||||||||
3. Full name of person(s) subject to the notification obligation: |
Lanstead Capital LP | ||||||||
4. Full name of shareholder(s) (if different from 3.): | |||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: |
1 March 2017 | ||||||||
6. Date on which issuer notified: | 3 March 2017 | ||||||||
7. Threshold(s) that is/are crossed or reached: |
3%, 4%, 5%, 6%, 7%, 8%, 9% | ||||||||
8. Notified details: | |||||||||
A: Voting rights attached to shares | |||||||||
Class/type of shares
if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | |||||
Direct | Direct | Indirect | Direct | Indirect | |||||
GB00BSNB6S51 | 0 | 0 | 12,075,000 | 12,075,000 | 9.55% | ||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | |||||||
N/A | |||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights | ||||||
N/A | Nominal | Delta | |||||||||
Total (A+B+C) | |||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||
12,075,000 | 9.55% | ||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | ||
N/A | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease to hold: | ||
12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | ||
14. Contact name: | Lisa De Vargas, Lanstead Partners Limited | |
15. Contact telephone number: | +1 (801) 895-3700 | |